China issues ethics guidelines for AI medical imaging research
The guidelines are intended to govern algorithm development, clinical validation and deployment of AI systems used to analyse scans such as CT, MRI, PET and ultrasound.
Independent intelligence on healthtech across Asia and the Middle East
The guidelines are intended to govern algorithm development, clinical validation and deployment of AI systems used to analyse scans such as CT, MRI, PET and ultrasound.
Alongside the shift to agentic AI, Singapore has updated its Artificial Intelligence in Healthcare Guidelines (AIHGle 2.0).
The framework updates guidance first issued in 2020 and is intended to work alongside South Korea's AI Basic Act, which took effect earlier this year.
The age of collaborative science should not be defined by how much reasoning machines can perform, argues HealthTechAsia's Vishnu Narayan.
Researchers surveyed 122 medical AI developers across Singapore, China, Hong Kong and the United Kingdom, finding that 67% worked for organisations that had not adopted any regulatory framework.
Malaysia has announced AI Malaysia Berhad, formalising and expanding the National AI Office, and Malaysia AI Safety Institute, intended to strengthen technical capacity.
The two countries could advance collaboration through joint research, talent development, digital infrastructure and public-benefit technologies.
Oversight would be decentralised, with sector regulators - in health, for example - responsible for AI within their own industries, coordinated by a national AI steering committee.
The policy dialogue centred on the leadership and governance considerations needed for responsible AI adoption. Subsequent workshops focused on practical applications, regional experience and priority use cases.